Articles related to Hepatology

Only about half of doctors in America identify themselves as “millionaires.” Like the rest of us, many physicians need to invest their money to grow it and build a retirement fund. And, increasingly, doctors are following the lead of the super-rich and investing in art. One-percenters are increasingly putting their money into art, which offers superior returns to the stock market averages with less risk and stress. Over time, the price of art tends to move in one direction — upwards — whereas stock prices can gyrate wildly and are prone to extreme volatility.

The U.S. Food and Drug Administration (FDA) held a two-day public meeting to discuss managing the potential side effects of gene therapies following the death of a boy with a rare neuromuscular disease. High doses of gene therapies are known to cause liver damage, and recent studies have also found a potential long-term cancer risk in mice and dogs treated with gene therapies.

There’s nothing like the sun when it comes to essential vitamin D. When your patients don’t get enough of it, fatigue and a host of other symptoms may arise. Here are 10 to keep an eye on if you think there may be a deficiency of vitamin D in your patients.

You want speedy access to comprehensive records. Clinical decision-making tools. Optimized communication and data exchange. EHRs should be as unique as you, so whether you’re looking to replace or implement your first, this list can get you started.

Although the 2020 numbers will likely look MUCH different, the Merritt Hawkins survey from 2019 showed increased gains from previous years. Of the 62 responses representing 93 hospitals, cardiovascular surgery drove the most revenue. Still, the outlook remains bleak post-pandemic.

Research from Johns Hopkins Kimmel Cancer Center showed that combination therapy of cabozantinib and nivolumab could make curative surgery possible for some liver cancer patients who would normally not be considered for such a procedure. Among 15 people with hepatocellular carcinoma (HCC) in the study who could not be treated previously with surgery, the drugs allowed 12 patients to undergo successful surgical removal of their cancer. Five of these 12 patients had only 10% or less of their tumor remaining after the drug treatment.